Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism
Authors
Keywords
-
Journal
ONCOGENE
Volume 34, Issue 10, Pages 1220-1230
Publisher
Springer Nature
Online
2014-03-24
DOI
10.1038/onc.2014.67
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers
- (2013) Wen Zhou et al. CANCER CELL
- A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia
- (2013) Jiewen Zhu et al. EMBO Molecular Medicine
- Complementary Interhelical Interactions between Three Buried Glu-Lys Pairs within Three Heptad Repeats Are Essential for Hec1-Nuf2 Heterodimerization and Mitotic Progression
- (2013) Bryan Ngo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nek2A contributes to tumorigenic growth and possibly functions as potential therapeutic target for human breast cancer
- (2012) Shuling Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore
- (2012) Emily A. Foley et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Ndc80 kinetochore complex directly modulates microtubule dynamics
- (2012) N. T. Umbreit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitosis-targeted anti-cancer therapies: where they stand
- (2012) K-S Chan et al. Cell Death & Disease
- The NDC80 complex proteins Nuf2 and Hec1 make distinct contributions to kinetochore–microtubule attachment in mitosis
- (2011) Lynsie J.R. Sundin et al. MOLECULAR BIOLOGY OF THE CELL
- Phosphorylation of the Ndc80 complex protein, HEC1, by Nek2 kinase modulates chromosome alignment and signaling of the spindle assembly checkpoint
- (2011) Randy Wei et al. MOLECULAR BIOLOGY OF THE CELL
- Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy
- (2011) Ivan Bièche et al. Molecular Cancer
- Mitotic catastrophe: a mechanism for avoiding genomic instability
- (2011) Ilio Vitale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells
- (2009) Ulrika Andréasson et al. AMERICAN JOURNAL OF HEMATOLOGY
- Synthesis and Biological Evaluation of a Series of Novel Inhibitor of Nek2/Hec1 Analogues
- (2009) Xiao-Long Qiu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance
- (2009) E. A. Perez MOLECULAR CANCER THERAPEUTICS
- Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
- (2008) Sanjeev Shangary et al. Annual Review of Pharmacology and Toxicology
- Small Molecule Targeting the Hec1/Nek2 Mitotic Pathway Suppresses Tumor Cell Growth in Culture and in Animal
- (2008) G. Wu et al. CANCER RESEARCH
- Increased expression and nuclear localization of the centrosomal kinase Nek2 in human testicular seminomas
- (2008) Federica Barbagallo et al. JOURNAL OF PATHOLOGY
- Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo
- (2008) E. Diaz-Rodriguez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started